Genetic Technologies Limited (GENE)
| Market Cap | 3.78M |
| Revenue (ttm) | 6.45M -6.5% |
| Net Income | -8.02M |
| EPS | -0.06 |
| Shares Out | 145.42M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 0.7650 |
| Day's Range | 0.7650 - 0.7650 |
| 52-Week Range | 0.6700 - 3.5900 |
| Beta | 0.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 13, 2025 |
About GENE
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. The company also markets BREVAGenplus to healthcare professionals in breast health c... [Read more]
Financial Performance
In 2024, Genetic Technologies's revenue was 9.67 million, a decrease of -6.52% compared to the previous year's 10.35 million. Losses were -12.02 million, 2.27% more than in 2023.
Financial numbers in AUD Financial StatementsNews
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / October 11, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip Small Stocks,...
Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2
MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-...
Genetic Technologies invited to join CancerIQ online platform
Genetic Technologies has negotiated a partnership agreement with Chicago-based CancerIQ. CancerIQ enables Healthcare Institutions and Clinics to support cancer prevention programs by supporting and si...
Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics
MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serio...
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024
GAINERS: Target Group (OTC: CBDY) shares closed up 33.33% at $0.00 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 28.57% at $0.01 Nextleaf Solutions (OTC: OILFF) shares closed up 19.05% at $0.07...
Genetic Technologies announces global launch of geneType on EasyDNA platform
Genetic Technologies announces the global launch of the geneType Risk Assessment portfolio on our wholly owned EasyDNA platform currently selling in 42 countries, setting the stage for the potential s...
Genetic Technologies intends to transition to capital light operations model
Genetic Technologies Limited has conducted an operations review and announces that it intends to transition to a capital light operations model – which is anticipated to result in an immediate…
Genetic Technologies Strategic Restructure Driving USA Sales Growth
CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious dis...
Genetic Technologies appoints Ziirsen as CFO, Company Secretary
Genetic Technologies (GENE) announces the appointment of Mark Ziirsen as Chief Financial Officer, CFO, and Company Secretary. Mark is a globally experienced ASX and Nasdaq listed CFO and company secre...
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, and seriou...
Genetic Technologies to enter Canadian, New Zealand markets
Genetic Technologies announced the introduction of geneType’s suite of genetic risk assessment tests to Canada and New Zealand. Dovetailing geneType’s recent expansion to the US market under its partn...
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
CHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious dise...
Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27
CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideli...
Genetic Technologies expands operation capacity in North America
Genetic Technologies announces the start of testing operations in the United States for its revolutionary geneType genetic risk assessment product series. GeneType’s multi-patented, clinically validat...
Genetic Technologies announces release of Comprehensive Risk Assessment test
Genetic Technologies announces the Company has released its novel Comprehensive Risk Assessment test that covers 100% of women at risk of developing breast and ovarian cancer. The innovative test, ava...
Genetic Technologies, Humanise Health host ‘Know Your Risk’ event
Genetic Technologies announced that the Know Your Risk event held yesterday at The Langham Pasadena has set a new standard for women’s health initiatives, highlighting the transformative potential of ...
Genetic Technologies files to sell 30M ordinary shares for holders
Represented by 1M American Depositary Shares.
Genetic Technologies, Wellworks for You sign B2B sales, marketing deal
Genetic Technologies announced the execution of a strategic joint sales & marketing agreement with US based Wellworks for You. As part of the agreement, Wellworks will incorporate the geneType portfol...
Genetic Technologies reports Q3 cash receipts A$1.8M
Commenting on the Company’s quarterly performance, Chief Executive Officer Simon Morriss said: “The team is making remarkable progress, especially in unlocking areas such as the pathway to profitabili...
Appendix 4C & Quarterly Business Update – March 2024
MELBOURNE, Australia, April 30, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, we...
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-...
Genetic Technologies Announces $2 Million Registered Direct Offering
MELBOURNE, Australia, April 19, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies"), a global leader in guideline-driven genomics-...
Genetic Technologies to establish precision oncology division, diagnostic tests
Genetic Technologies announces the Company has established a precision oncology division and announced its highly anticipated portfolio of new diagnostic tests under its geneType precision oncology br...
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / April 12, 2024 / RedChip Companies will air interviews with Genetic Technologies Limited (NASDAQ:GENE) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks, Big Money™...
Genetic Technologies to pilot GeneType in Breast Screen centers across U.S.
Genetic Technologies announces the company is establishing a clinical implementation study with breast imaging centers across New York, Miami and Houston. The initiative will pilot the integration of ...